These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 19304279

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease.
    Inoue T, Kotooka N, Morooka T, Komoda H, Uchida T, Aso Y, Inukai T, Okuno T, Node K.
    Am J Cardiol; 2007 Aug 15; 100(4):569-74. PubMed ID: 17697807
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V, Winkler K, Drechsler C, Lilienthal J, März W, Wanner C, German Diabetes and Dialysis Study Investigators.
    Am J Kidney Dis; 2009 Nov 15; 54(5):902-11. PubMed ID: 19781835
    [Abstract] [Full Text] [Related]

  • 5. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study.
    Schnabel R, Messow CM, Lubos E, Espinola-Klein C, Rupprecht HJ, Bickel C, Sinning C, Tzikas S, Keller T, Genth-Zotz S, Lackner KJ, Münzel TF, Blankenberg S.
    Eur Heart J; 2008 Mar 15; 29(5):649-57. PubMed ID: 18263867
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin.
    Aso Y, Yamamoto R, Wakabayashi S, Uchida T, Takayanagi K, Takebayashi K, Okuno T, Inoue T, Node K, Tobe T, Inukai T, Nakano Y.
    Diabetes; 2006 Jul 15; 55(7):1954-60. PubMed ID: 16804063
    [Abstract] [Full Text] [Related]

  • 8. Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy.
    Kato K, Osawa H, Ochi M, Kusunoki Y, Ebisui O, Ohno K, Ohashi J, Shimizu I, Fujii Y, Tanimoto M, Makino H.
    Clin Endocrinol (Oxf); 2008 Mar 15; 68(3):442-9. PubMed ID: 17970779
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. High-molecular-weight adiponectin is a predictor of progression to metabolic syndrome: a population-based 6-year follow-up study in Japanese men.
    Seino Y, Hirose H, Saito I, Itoh H.
    Metabolism; 2009 Mar 15; 58(3):355-60. PubMed ID: 19217451
    [Abstract] [Full Text] [Related]

  • 12. High molecular weight adiponectin correlates positively with myeloperoxidase in patients with type 2 diabetes mellitus.
    Bobbert P, Rauch U, Stratmann B, Goldin-Lang P, Antoniak S, Bobbert T, Schultheiss HP, Tschoepe D.
    Diabetes Res Clin Pract; 2008 Nov 15; 82(2):179-84. PubMed ID: 18778866
    [Abstract] [Full Text] [Related]

  • 13. Decreased ratio of high-molecular-weight to total adiponectin is associated with angiographic coronary atherosclerosis severity but not restenosis.
    Liang KW, Lee WJ, Lee WL, Ting CT, Sheu WH.
    Clin Chim Acta; 2009 Jul 15; 405(1-2):114-8. PubMed ID: 19397903
    [Abstract] [Full Text] [Related]

  • 14. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N, Hara K, Yatsuka C, Nakano T, Matsumoto S, Suetsugu M, Nakamachi T, Takebayashi K, Inukai T, Haruki K, Aso Y.
    Metabolism; 2009 Oct 15; 58(10):1470-6. PubMed ID: 19592051
    [Abstract] [Full Text] [Related]

  • 15. Adiponectin isoforms are not associated with the severity of coronary atherosclerosis but with undiagnosed diabetes in patients affected by stable CAD.
    Rizza S, Clementi F, Porzio O, Cardellini M, Savo A, Serino M, Chiricolo G, Romeo F, Lauro R, Federici M.
    Nutr Metab Cardiovasc Dis; 2009 Jan 15; 19(1):54-60. PubMed ID: 18472407
    [Abstract] [Full Text] [Related]

  • 16. Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany.
    Koenig W, Khuseyinova N, Baumert J, Meisinger C, Löwel H.
    J Am Coll Cardiol; 2006 Oct 03; 48(7):1369-77. PubMed ID: 17010797
    [Abstract] [Full Text] [Related]

  • 17. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
    Vlek AL, van der Graaf Y, Spiering W, Visseren FL, SMART study group.
    J Hum Hypertens; 2008 May 03; 22(5):358-65. PubMed ID: 18273039
    [Abstract] [Full Text] [Related]

  • 18. Effects of losartan on serum total and high-molecular weight adiponectin concentrations in hypertensive patients with metabolic syndrome.
    Uchida T, Shimizu M, Sakai Y, Nakano T, Hara K, Takebayashi K, Inoue T, Node K, Inukai T, Takayanagi K, Aso Y.
    Metabolism; 2008 Sep 03; 57(9):1278-85. PubMed ID: 18702955
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Changes in adiponectin multimer distribution in response to atorvastatin treatment in patients with type 2 diabetes.
    von Eynatten M, Liu D, Bluemm A, Schuster T, Baumann M, Lutz J, Heemann U, Dugi KA, Nawroth PP, Bierhaus A, Humpert PM.
    Clin Endocrinol (Oxf); 2009 Jul 03; 71(1):27-32. PubMed ID: 18778396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.